142 related articles for article (PubMed ID: 36754860)
1. Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour.
Sugino H; Iwata S; Satomi K; Mori T; Nobusawa S; Nagashima T; Matsushita Y; Yatabe Y; Ichimura K; Kawai A; Yoshida A
Histopathology; 2023 May; 82(6):937-945. PubMed ID: 36754860
[TBL] [Abstract][Full Text] [Related]
2. NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma.
Flucke U; Tops BB; Verdijk MA; van Cleef PJ; van Zwam PH; Slootweg PJ; Bovée JV; Riedl RG; Creytens DH; Suurmeijer AJ; Mentzel T
Virchows Arch; 2012 Jun; 460(6):621-8. PubMed ID: 22569967
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of five unusual cases of intraosseous myoepithelial carcinomas, mimicking conventional primary bone tumours, including EWSR1 rearrangement in one case.
Rekhi B; Joshi S; Panchwagh Y; Gulia A; Borges A; Bajpai J; Jambehekar NA; Pant V; Mandholkar M; Byregowda S; Puri A
APMIS; 2016 Apr; 124(4):278-90. PubMed ID: 26768122
[TBL] [Abstract][Full Text] [Related]
5. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
7. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
[TBL] [Abstract][Full Text] [Related]
9. Histopathological, immunohistochemical and molecular spectrum of myoepithelial tumours of soft tissues.
Rekhi B; Sable M; Jambhekar NA
Virchows Arch; 2012 Dec; 461(6):687-97. PubMed ID: 23097005
[TBL] [Abstract][Full Text] [Related]
10. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
12. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
Filion C; Motoi T; Olshen AB; Laé M; Emnett RJ; Gutmann DH; Perry A; Ladanyi M; Labelle Y
J Pathol; 2009 Jan; 217(1):83-93. PubMed ID: 18855877
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
14. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
[TBL] [Abstract][Full Text] [Related]
15. Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm.
Kinoshita I; Kohashi K; Yamamoto H; Yamada Y; Inoue T; Higaki K; Teramoto N; Oshiro Y; Nakashima Y; Oda Y
Histopathology; 2021 Oct; 79(4):629-641. PubMed ID: 33932047
[TBL] [Abstract][Full Text] [Related]
16. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.
Demicco EG; Wang WL; Madewell JE; Huang D; Bui MM; Bridge JA; Meis JM
Am J Surg Pathol; 2013 May; 37(5):752-62. PubMed ID: 23588370
[TBL] [Abstract][Full Text] [Related]
17. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
[TBL] [Abstract][Full Text] [Related]
18. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
Stacchiotti S; Pantaleo MA; Astolfi A; Dagrada GP; Negri T; Dei Tos AP; Indio V; Morosi C; Gronchi A; Colombo C; Conca E; Toffolatti L; Tazzari M; Crippa F; Maestro R; Pilotti S; Casali PG
Eur J Cancer; 2014 Jun; 50(9):1657-64. PubMed ID: 24703573
[TBL] [Abstract][Full Text] [Related]
19. TAF15::NR4A3 gene fusion identifies a morphologically distinct subset of extraskeletal myxoid chondrosarcoma mimicking myoepithelial tumors.
Warmke LM; Wang WL; Baumhoer D; Andrei V; Ameline B; Baker ML; Kerr DA
Genes Chromosomes Cancer; 2023 Oct; 62(10):581-588. PubMed ID: 37057757
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
